With the continuous development of the pharmaceutical industry, more and more pharmaceutical companies now recognize the importance of R&D innovation. Because it has become a yardstick for measuring the competitiveness of a pharmaceutical company. Nowadays, R&D and innovation strength has become a yardstick for the competitiveness of a pharmaceutical company and the change of market value. In particular, the CRO (Contract Research Organization) company is more focused on the synthesis of small batches of new drug compounds in the laboratory stage. In order to strengthen research and development, a pharmaceutical CRO enterprise customer of YK wants to find a suitable and efficient laboratory emulsifier equipment. In the end, the customer procurement representative selected the fifth-generation high-end laboratory homogenizer as the new experimental equipment of the customer enterprise through multi-party understanding and screening.
This laboratory vacuum homogenizing emulsifier unit is the fifth generation laboratory emulsifier equipment of YK. After the first four generations of technology precipitation, the equipment is the industry’s advanced laboratory mixed homogeneous mixing equipment in terms of appearance, configuration, function and performance and stability of the whole machine! The design of the whole machine fully takes into account the various process requirements of laboratory development and small-scale production. Therefore, this machine has been welcomed by domestic and foreign corporate customers and even universities and research institutions! If you are interested in this device, please contact us!